- Home
- HRMY vs PINC Comparison
HRMY vs PINC Comparison
Compare HRMY & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- PINC
- Stock Information
- Founded
- HRMY 2017
- PINC 2013
- Country
- HRMY United States
- PINC United States
- Employees
- HRMY N/A
- PINC N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- PINC Other Consumer Services
- Sector
- HRMY Health Care
- PINC Consumer Discretionary
- Exchange
- HRMY Nasdaq
- PINC Nasdaq
- Market Cap
- HRMY 1.9B
- PINC 1.8B
- IPO Year
- HRMY 2020
- PINC 2013
- Fundamental
- Price
- HRMY $26.11
- PINC $28.01
- Analyst Decision
- HRMY Strong Buy
- PINC Hold
- Analyst Count
- HRMY 10
- PINC 6
- Target Price
- HRMY $50.80
- PINC $26.08
- AVG Volume (30 Days)
- HRMY 1.0M
- PINC 2.1M
- Earning Date
- HRMY 10-28-2025
- PINC 11-04-2025
- Dividend Yield
- HRMY N/A
- PINC 3.00%
- EPS Growth
- HRMY 58.41
- PINC N/A
- EPS
- HRMY 3.10
- PINC 0.22
- Revenue
- HRMY $772,527,000.00
- PINC $1,012,647,000.00
- Revenue This Year
- HRMY $19.94
- PINC N/A
- Revenue Next Year
- HRMY $16.65
- PINC $3.13
- P/E Ratio
- HRMY $8.37
- PINC $41.18
- Revenue Growth
- HRMY 17.74
- PINC N/A
- 52 Week Low
- HRMY $25.58
- PINC $17.23
- 52 Week High
- HRMY $41.61
- PINC $28.79
- Technical
- Relative Strength Index (RSI)
- HRMY 30.89
- PINC 61.48
- Support Level
- HRMY $25.95
- PINC $27.73
- Resistance Level
- HRMY $26.97
- PINC $28.05
- Average True Range (ATR)
- HRMY 0.79
- PINC 0.19
- MACD
- HRMY 0.19
- PINC -0.10
- Stochastic Oscillator
- HRMY 26.11
- PINC 49.55
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.